Prosecution Insights
Last updated: October 04, 2026

VASCULAR TECHNOLOGY INC.

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

VASCULAR TECHNOLOGY INC. is managing 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. Unlike portfolios with distributed workloads, these actions are consolidated under 1 distinct examiner and 1 distinct art unit. This concentration suggests a high degree of technical overlap in the company's current filings, as 1 distinct art unit is sufficient to cover the subject matter of both pending applications.

DARB, HAMZA A. is the busiest examiner, overseeing both of the 2 pending office actions. This concentration means that the company's current prosecution success is tied to the specific interpretations and examination style of a single examiner across all active filings. Having 2 pending office actions with DARB, HAMZA A. allows the practitioner to potentially apply consistent arguments across the portfolio, as the same individual is reviewing the technical merits of both cases.

The reliance on 1 distinct examiner for 2 pending office actions in Medical Devices & Mechanical Engineering creates a singular point of contact for the firm. While this simplifies communication, it also increases the impact of DARB, HAMZA A. on the company's overall patent strategy. Practitioners should closely analyze the previous rulings of this examiner to anticipate how the 2 pending office actions will be resolved.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
0
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DARB, HAMZA A. 2 74.4% +30.9%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18332460 REMOTELY CONTROLLED SUCTION/IRRIGATION FOR SURGERY DARB, HAMZA A. 27d
18318228 REMOTELY CONTROLLED SUCTION/IRRIGATION FOR SURGERY DARB, HAMZA A. 40d

Top Art Units

Art UnitApps
3783 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18332460 REMOTELY CONTROLLED SUCTION/IRRIGATION FOR SURGERY DARB, HAMZA A. 3783 §103 Final Rejection 27d Pending Jun 09, 2023
18318228 REMOTELY CONTROLLED SUCTION/IRRIGATION FOR SURGERY DARB, HAMZA A. 3783 §103 Final Rejection 40d Pending May 16, 2023

Managing VASCULAR TECHNOLOGY INC.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month